Good morning and good afternoon, everyone, and welcome to Haypp Group's Q2 results. My name is Gavin O’Dowd and together with our CFO, Peter Deli, we will take you through today's presentation starting at slide three, which is the agenda for today. I will take you through an overview of Haypp and the Q2 performance highlights. And Peter will take us through the consumer, financial, and segment performances before handing back to me for progress on our key strategic priority markets and an outlook.
I would like to take you to slide five to remind you of some of the key dynamics around our business. We are an online retailer of reduced-risk products with a strong focus on nicotine pouches, which as of today make up over 70% of our volumes. We have multiple storefronts per market, and we operate in five markets in Europe, in the US, and we have also recently launched in Saudi Arabia. Approximately 90% of our revenue comes from product sales, with sales of M&I to brand owners accounting for just over 10%. While jurisdictional complexity around the sale of nicotine is often viewed as a hardship, given our expertise and scale, we view it as a barrier to entry. We are targeting to approximately double our 2020 revenue by 2028 and increase our 2024 EBIT by 3 to 4x.
Moving to slide six. The scale of market growth potential in our existing geographic footprint is determined by the US and the UK. While the UK is a distant second, it has some very favorable long-term dynamics. Continuing on to slide seven, the US and the UK are also the two markets with extremely low online penetration rates, reflecting the early stages of the category lifecycle, including the historically limited assortment in the US. Hence, these are two markets to which we have dedicated significant resources in recent quarters. We will touch on this more throughout our presentation.
Moving into the quarterly performance updates and remaining on slide seven for a moment. This is the first quarter. This quarter has been our fastest volume and sales year-on-year growth since we IPO'd five years ago. It is also our highest ever gross margin. Moving to slide nine, we are happy to see continued acceleration in nicotine pouches to 45% year-on-year growth in absolute volume. This is by far our fastest year-on-year nicotine pouch growth in the history of the group. Growth markets have been a significant contributor with 91% year-on-year growth, and now account for almost half of our nicotine pouch volume; following a strong performance, the growth segment accounted for 71% of our nicotine pouch growth. This momentum is underpinned by the group's investment focus and supports our future growth expectations.
Moving to our performance highlights on slide ten. An increase in active consumers was the primary driver of our growth. However, an increased share of consumption among existing consumers in our core markets also contributed to the 28% volume growth. Gross margins were up slightly to a record high, generating a gross profit increase of 29%. This consisted of a substantial increase in Media & Insights, which was partially reinvested into the consumer offer. To further accelerate the flywheel year on year, we have materially increased our investment and capabilities in the US and the UK. This, combined with increases in marketing expenditure, While the window to do so remains open, this has led to a reduction in the EBIT margins, which we expect to level off and to continue at this level for the remainder of this year, before trending back towards our 2026 guidance. On slide 11, we show the actual performance of each of these KPIs and their relative change versus the prior year; growth in consumers flowed through to orders and volume, leading to our fastest net sales growth in five years, which in turn led to our highest ever gross margins. The planned investments, predominantly in the US and the UK, have temporarily reduced our EBIT.
With that, I will hand over to Peter. Thank you, Gavin, and good morning. Good afternoon, everyone. Let me take you through our Q2 performance. The headline this quarter is strong broad-based growth and the highest organic growth rate. Since our IPO, we have accelerated both our top line and our consumer base. Our fundamentals remain solid and exactly as planned. We are carrying a deliberate level of investment that is weighing on near-term profit. Let me continue. Let me now go a little deeper, starting with our consumers, because ultimately, consumer growth is what underpins everything else in the model. Going to slide 13, this slide shows the continued strength in our consumer base. Active consumers reached a new all-time high, up 24.4% year-on-year. There are two reinforcing trends behind it: rapid growth in all growth markets and core turning firmly into growth. The standout is the growth segment, where active consumers were up 24.2%, driven primarily by the US and UK. Our marketing is showing clear traction with strong conversion and repeat purchase behavior, and in core markets, active consumers grew 9.3%, a meaningful improvement versus the declines we saw earlier last year. This is supported by a growing number of nicotine pouch consumers and a stabilizing Snus base. The momentum in both core and growth markets gives us confidence that our acquisition strategy is working. Paired with sustained strong retention, we are building a solid foundation for continued volume and sales acceleration. Slide 14. Here we break down our performance by category. Nicotine pouches remain the engine; nicotine pouch weight in group volume supports future growth, with the US and UK as the primary market drivers. In core markets, nicotine pouches are now around 54% of volume and still growing at high-teen rates, taking meaningful market share. Snus volume decline continues to moderate since Q4 last year, helped by an enhanced consumer offer designed to capture mixed-category household purchases in Swedish homes. On Vape & HNB, the UK discontinuation reduced the year-on-year growth, but the underlying trajectory is expected to continue with strong growth in both Germany and Sweden.
Important to note that volume growth is ahead of consumer-based growth across all markets, signaling that our offering resonates well with consumers and we are gaining share of wallet. Overall, the category dynamics remain very supportive and our scale positions us well to capture the ongoing shift toward RRPs. Now let me turn to the financials and walk you through the P&L and the balance sheet. Starting with the net sales on slide 16. We saw further acceleration in our top line. Net sales grew 27.7% as reported and 27.1% at constant currency. This is the highest constant currency growth rate we have delivered since our IPO. In absolute terms, net sales reached almost 1.2 billion SEK. The negative translation impact is driven by the NOK to SEK exchange rate, with the US dollar to SEK exchange rate partly offsetting it. What I am particularly pleased about is that all critical parts of the business contributed. Nicotine pouches remained the key growth driver, and given that nicotine pouches represent above 70% of our volume. That strong growth, plus the rising share of sales, creates a positive mix effect within the nicotine pouches category. The US and UK are the key drivers with solid mid-teen growth in the core markets. Price mix in the nicotine pouch segment was negative in the quarter, driven by the growth segment, mainly the US business. I want to stress that these promotions are manufacturer-led and margin-neutral for us. There is an offset in our cost of goods sold. Snus stabilized after a few challenging quarters in 2025. The decline is lower now than what we anticipated at our Capital Markets Day, helped by the improved Swedish consumer offer. Vape & HNB contributed to growth despite the UK discontinuation, with Sweden and Germany volume up by 70%.
On slide 17. Let me talk to you about our gross profit. We delivered gross profit of 229 million SEK this quarter. The major step up in absolute terms, up 29.2% year-on-year, saw gross profit growth slightly ahead of net sales. So gross margin improved by a marginal 0.2 percentage points to 19.5%. Within the margin, there are two opposing forces. The fast growth of Media & Insights lifted the margin, adding 0.9 points to bring Media & Insights gross margin contribution to 11.9% with growth across all key markets. We then reinvested much of that incremental benefit back into our consumer offer, mainly targeted pricing, which we believe is the right trade-off while the acquisition window is open.
Moving to slide 18. Overheads increased in the quarter, and this was fully expected from last quarter. We break the base into three elements: marketing, fulfillment, and G&A. And total overhead was 14.8% of net sales. Marketing at 1.8% increased as we leaned into consumer acquisition in the US and UK. While the opportunity window is open, we are seeing substantial increases in new consumer acquisition rates in both markets. We are pleased with the performance of some channels, particularly with high purchase intent, lower funnel marketing, and we will continue to deploy capital. Subject to the ongoing performance, we will be efficient and disciplined with the capital we deploy. Fulfillment at 1.6% is where our scale benefit shows; the cost base grew 25%, while volume grew 28%. So we are growing into our warehouse infrastructure. The UK move to a larger automated facility, which will extend that, and G&A at 11.3% is the biggest driver of the increase. This is mainly driven by the organizational build-out in the US and UK and within our central functions, including AI. Some of the structure is deliberately ahead of the current business because the skill sets and local focus are critical to our long-term success. We expect G&A intensity to moderate, and as a percentage of net sales, we do not expect further increases for H2. Given the size of the group's G&A cost base relative to adjusted EBIT, management sees significant potential to improve productivity and scalability through targeted AI investments. These initiatives are expected to further improve operational efficiency across the organization.
Moving to slide 19. This brings us to adjusted EBIT, which was 28.6 million with a margin of 2.4%, down from 4.2% last year. I want to be transparent about this. The compression is entirely by design. Higher gross profit and a stable gross margin are working in our favor and show that our business model is robust. But the investments in G&A, mainly personnel and in marketing, more than offset that at the EBIT line in the growth segment, accounting for the compression. We are prioritizing consumer acquisition and market share gains in the US and UK, with both markets already showing substantial growth versus last year; we expect this investment phase to continue through 2026, with margin expansion resuming as scale benefits flow through in 2027 and 2028. Slide 20.
Finally, on the balance sheet, working capital and leverage. The sequential increase in inventory mainly reflects opportunistic inventory build across several markets, with some additional US stock built for new product launches and stock in our newly established Swiss warehouse, accounting for the remainder. Net working capital turnover remained in line with the range of prior quarters despite the opportunistic stock builds. Net debt increased sequentially, driven by higher working capital and increased lease commitments, and leverage moved from 0.2 times to around one times on a net debt to last 12 months adjusted EBITDA basis. That is still a low and very manageable level, and we remain disciplined in managing working capital as we scale.
Let me now turn to segment performance. Taking growth and core in turn, this is where you can really see the two engines of the model: growth driving acceleration and future share, and core providing the profitable, cash-generative foundation. Starting with the Growth segment on slide 22. This is where we see the most significant acceleration. Active consumers grew 74.2%. Orders grew 72.3%. This is a notable increase in new customers during the quarter. Explaining the slower growth of the order number. Total volume was up 80%. Nicotine. Nicotine pouch volume is up 91%. The difference is driven by the fact that the UK growth segment represents 47% of the group's nicotine pouch volume. Both the US and UK delivered exceptional performance, with volumes up by 125% and 113% respectively. Net sales grew 57%, or 62% at constant currency, and the segment represents a 30% share of the group net sales. The gap between net sales growth and volume growth is driven by manufacturer-financed price reductions. Gross margin was 18.9%, down 5.5 points. That reflects an exceptionally strong prior-year comparison and the deliberate investment into our consumer offer this quarter. EBITDA was negative at 32.5 million SEK. This is expected and reflects the investment phase we are in as we build local teams and scale acquisition. Those investments are what accelerate our long-term share capture. And they are already translating into very strong consumer and volume growth to support the further development of this segment. We automated our UK warehouse and localized our operations in Switzerland to improve consumer experience in both markets.
As communicated earlier, we exited Austria effective July 1st. Austria generated less than 9 million SEK in revenue in Q2 2026. Overall growth is performing in line with our expectations and is the primary driver of our long-term revenue and EBIT expansion.
Moving to slide 23. In the core segment, we delivered steady, predictable performance consistent with the role it plays in the portfolio. Active consumers grew 9.3% and total volume 11.3%, driven by nicotine pouches and supported by the improved Snus offer. Nicotine pouches volume up 19%. Volume growth ahead of consumer growth is a clear sign we are increasing our share of wallet. Net sales grew 18.2%, or 15.8% at constant currency. Positive price mix driven by increased Media & Insights revenue led to a gross margin increase of 2.1 points to 19.7%, and EBITDA grew 33% to 87.9 million SEK, a healthy 10.7% margin. So while growth is the accelerator, core remains the foundation of our margin and cash generation, and its rising nicotine pouch penetration supports long-term margin expansion.
Strong growth across both segments reflects the continued execution of our strategy and supports our ambition to drive further profit expansion over time. With this, I hand the word back to Gavin. Guide us through the strategic priorities. Thank you, Peter. I would now like to take you through our priority markets. Moving to slide 25 and the US. I would like to touch on how the market conditions are changing and how these changes are positively impacting our business. In May this year, the FDA announced a level of enforcement discretion, which we expect to accelerate new product introductions significantly versus our Q1 call. This rapid acceleration of new product launches has already begun and is expected to continue well beyond 2026. This decision is likely to support market growth rates as both more consumers find suitable nicotine pouch products to switch to, and more existing dual users switch entirely to nicotine pouches. This US environment is becoming analogous to the environment which began in Sweden and Norway approximately six years ago, and is an environment in which we have had strong success. Assortment has historically been an accelerator for Haypp Group, as our operating model enables us to carry a significantly larger range of quality products. In addition, our stores are designed to help consumers navigate product differences to find the product that is right for them. While expectations of some new product launches were a material factor in our decision to invest in the US, the new outlook suggests an even better opportunity than initially expected. During the quarter, we have experienced strong performance in new customer acquisition, particularly from consumers with high purchasing intent. We will continue to refine our marketing while the opportunity remains. In addition, we have also improved our referral and loyalty programs. While still early days, the improvements are having a meaningful impact. The range of activities has led to 125% year-on-year volume growth in a market which is growing between 15% and 20%.
Moving to the UK on the next slide. Slide 26.
The Tobacco and Vapes Bill, which received royal assent at the end of April, appears to remain strongly supported by the new government. We continue to expect the secondary legislation to iron out the remaining details, raising the compliance requirements for other retailers. The secondary legislation will be implemented in pieces throughout this year and 2027, with some of the more notable impacts expected in June of 2027. As a reminder, these changes are expected to further consolidate our market-leading position and accelerate migration to online. In addition, we expect the ultra-strong segment, which we don't sell, to be banned, removing our assortment disadvantage. I would also like to draw your attention to some of our key highlights in the UK market during the quarter. The enhanced local capabilities, which we built up in Q1, are now fully embedded and already performing well, leading to a continued acceleration in new consumer inflow while maintaining our excellent retention rates. Our performance is supported by a high level of brand owner support and high demand for both our Media & Insights. We successfully automated our UK warehouse to support continued growth over the long term. This range of activities has led to strong triple-digit growth in the quarter, which is over twice that of the estimated overall market growth.
Moving to the next slide, slide 27. There has been little change in either European regulation or Swedish litigation since last quarter. The Tobacco Tax Directive continues to be negotiated, with a first draft still expected this year. The European Commission recently completed a public consultation on the third Tobacco Products Directive. Both directives are expected to undergo revision during the negotiation period from member states later this year. Regarding the Swedish litigation, Haypp is still awaiting a decision on the appeal from the Supreme Administrative Court. Haypp does not expect any material impact from the decision. Moving to the penultimate slide. Slide 29. In summary, our markets continue to evolve favorably with continued category growth, leading to sustainable regulation in line with the Haypp operating model.
Investment in capabilities and marketing in the US and the UK are driving rapid consumer-based growth, which in turn has led to our fastest organic growth rates since before we IPO'd in 2021. This growth has fed our flywheel model, leading to the highest ever gross margin while continuing to further invest into the consumer offer. Our decision to increase our DNA to drive this growth is complete and is expected to stabilize at current levels for the rest of this year and scale in future years. We are on track to deliver our 2028 revenue and profit targets. Moving to the next slide. To recap on those targets, which are set for 2028 revenue growth of 18% to 25% from 2024 at constant currency, and a 5.5% adjusted EBIT margin, plus or minus 150 basis points, subject to the investment opportunities which remain at that time before handing over to the operator. I'd like to thank the team for the great work in recent quarters, which led to the strong performance in this quarter. With that, I will hand over to the operator for questions.